Page values for "Memantine"
From Pharmacopedia
More actions
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Memantine |
| brand | String | Namenda (IR), Namenda XR (extended-release), Namzaric (with donepezil) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Anti-dementia medicines|Anti-dementia medicine]] • [[:Category:NMDA receptor antagonists|NMDA receptor antagonist (uncompetitive • low-affinity)]] • [[:Category:Adamantanes|Adamantane derivative]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000017-QINU`"', '"`UNIQ--vote-00000018-QINU`"', '"`UNIQ--vote-00000019-QINU`"', '"`UNIQ--vote-0000001A-QINU`"' |
| starting_dose | String | 5 mg PO once daily; titrate by 5 mg weekly to target 10 mg PO BID. XR formulation: 7 mg/day, titrate to 28 mg/day |
| preparations | String | IR tablets 5, 10 mg; oral solution 2 mg/mL; XR capsules 7, 14, 21, 28 mg |
| fda_max | String | 20 mg/day (IR); 28 mg/day (XR) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | Cognitive effect emerges gradually over weeks to months; symptomatic effect only |
| duration | String | BID dosing for IR; once-daily for XR |
| halflife | String | 60-100 hours (long)'"`UNIQ--ref-0000001B-QINU`"' |
| bioavailability | String | ~100% (oral)'"`UNIQ--ref-0000001C-QINU`"' |
| pregnancy | String | Limited human data; rarely indicated in pregnancy given the patient population.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |